IN2003CH00929A - - Google Patents

Download PDF

Info

Publication number
IN2003CH00929A
IN2003CH00929A IN929CH2003A IN2003CH00929A IN 2003CH00929 A IN2003CH00929 A IN 2003CH00929A IN 929CH2003 A IN929CH2003 A IN 929CH2003A IN 2003CH00929 A IN2003CH00929 A IN 2003CH00929A
Authority
IN
India
Prior art keywords
sub
pcaf
mum
compounds
useful
Prior art date
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN929CH2003 priority Critical patent/IN2003CH00929A/en
Priority to US10/579,219 priority patent/US7402706B2/en
Priority to PCT/IB2004/052294 priority patent/WO2005047457A2/en
Priority to EP04799059A priority patent/EP1694622B1/en
Priority to AT04799059T priority patent/ATE549309T1/de
Publication of IN2003CH00929A publication Critical patent/IN2003CH00929A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/24All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN929CH2003 2003-11-13 2003-11-13 IN2003CH00929A (ru)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IN929CH2003 IN2003CH00929A (ru) 2003-11-13 2003-11-13
US10/579,219 US7402706B2 (en) 2003-11-13 2004-11-04 Polyisoprenylated benzophenones and their isomers as inhibitors of histone acetyltransferases and uses thereof
PCT/IB2004/052294 WO2005047457A2 (en) 2003-11-13 2004-11-04 Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof
EP04799059A EP1694622B1 (en) 2003-11-13 2004-11-04 Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof
AT04799059T ATE549309T1 (de) 2003-11-13 2004-11-04 Polyisoprevonl benzophenone als inhibitoren von histonacetyltransdferasen und anwendungen dafür

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN929CH2003 IN2003CH00929A (ru) 2003-11-13 2003-11-13

Publications (1)

Publication Number Publication Date
IN2003CH00929A true IN2003CH00929A (ru) 2008-10-06

Family

ID=34586954

Family Applications (1)

Application Number Title Priority Date Filing Date
IN929CH2003 IN2003CH00929A (ru) 2003-11-13 2003-11-13

Country Status (5)

Country Link
US (1) US7402706B2 (ru)
EP (1) EP1694622B1 (ru)
AT (1) ATE549309T1 (ru)
IN (1) IN2003CH00929A (ru)
WO (1) WO2005047457A2 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022254465A1 (en) * 2021-06-02 2022-12-08 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Small molecule modulator targeting a rare histone modification regulating adipogenesis and pharmaceutical formulation thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732475B2 (en) 2005-07-14 2010-06-08 Takeda San Diego, Inc. Histone deacetylase inhibitors
AR057579A1 (es) * 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
KR101005173B1 (ko) * 2008-02-18 2011-01-04 인제대학교 산학협력단 항산화 및 세포독성 활성을 나타내는 물레나물과의가르시니아 오블롱기폴리아로부터 추출된 분획물 및그로부터 분리된 화합물
EP2475769B1 (en) * 2009-09-07 2016-11-09 Jawaharlal Nehru Centre for Advanced Scientific Research Inhibition of histone acetyltransferases by ctk7a and methods thereof
AU2011340203B2 (en) 2010-12-09 2015-11-26 Indus Biotech Private Limited A complex of Garcinol, Cyclodextrin and method thereof
WO2013148114A1 (en) * 2012-03-30 2013-10-03 University Of Florida Research Foundation, Inc. P300/cbp inhibitors and methods of use
GB201215942D0 (en) * 2012-09-06 2012-10-24 Glaxo Group Ltd Method of treatent
JP2020525425A (ja) * 2017-06-22 2020-08-27 サミ ラブズ リミテッド 小胞体ストレスの治療管理のためのガルシノール組成物
MA50250A (fr) 2017-09-15 2020-07-22 Forma Therapeutics Inc Compositions de tétrahydroimidazo quinoléine utilisées en tant qu'inhibiteurs de cbp/p300
KR20210025631A (ko) 2018-06-29 2021-03-09 포르마 세라퓨틱스 인크. Creb 결합 단백질(cbp)의 저해
US11801243B2 (en) 2020-09-23 2023-10-31 Forma Therapeutics, Inc. Bromodomain inhibitors for androgen receptor-driven cancers
US11795168B2 (en) 2020-09-23 2023-10-24 Forma Therapeutics, Inc. Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08259493A (ja) * 1995-03-20 1996-10-08 Sugimoto Masami 抗mrsa活性物質

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022254465A1 (en) * 2021-06-02 2022-12-08 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Small molecule modulator targeting a rare histone modification regulating adipogenesis and pharmaceutical formulation thereof

Also Published As

Publication number Publication date
US20070254961A1 (en) 2007-11-01
EP1694622A2 (en) 2006-08-30
WO2005047457B1 (en) 2005-12-01
WO2005047457A2 (en) 2005-05-26
EP1694622B1 (en) 2012-03-14
WO2005047457A3 (en) 2005-08-04
US7402706B2 (en) 2008-07-22
ATE549309T1 (de) 2012-03-15

Similar Documents

Publication Publication Date Title
IN2003CH00929A (ru)
CY1110498T1 (el) Παραγωγα πυραζολης ως αναστολεις των κινασων τυροσινης υποδοχεα
DE60137329D1 (de) Zusammensetzungen zur behandlung von diabetes die einen dp iv-inhibitoren und einen andere antidiabetikum enthalten
NO20050570L (no) Nye forbindelser, preparater og fremgangsmater for behandling av inflammasjonssykdommer og -tilstander
CY2014028I1 (el) Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης
NO20055741L (no) Nye kjemiske forbindelser
DE602004021685D1 (de) Markierungsfreier nachweis biologischer und chemischer stoffe mittels evaneszenzfeld
BRPI0508464B8 (pt) sulfonilpirróis, composição farmacêutica compreendendo os mesmos e uso dos mesmos
ATE386028T1 (de) Zyklohexylsulfone als gamma-sekretase-inhibitoren
UY27993A1 (es) Derivados de 4-pirrolidino-fenil-bencil eter
ATE347451T1 (de) Abgabevorrichtung
ATE542804T1 (de) 5-phenyl-pentansäurederivate als matrixmetalloproteinase-inhibitoren zur behandlung von asthma und anderen erkrankungen
ATE424823T1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate als arzneimittel zur behandlung von unfruchtbarkeit
DE60326069D1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
NO20055657D0 (no) Nye bioisostaererav aktinonin
ATE406895T1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin- derivate als arzneimittel zur behandlung von unfruchtbarkeit
DK1778622T3 (da) Para-alkyl-substituerede N-(4-hydroxy-3-methoxy-benzyl)-kanelsyreamider og anvendelse deraf til fremstilling af lægemidler
NO20053071L (no) Kalsilytiske forbindelser.
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
ITRN20030024A1 (it) Dispositivo per il prelievo di campioni biologici e/o chimici.
NO20031844D0 (no) Nye askorbinsyreforbindelser, syntesemetoder og anvendelse derav
ITFI20020034A1 (it) Metodo e dispositivo per l'analisi spettrale di un segnale ecografico
DE60331359D1 (de) Kynurenine 3-hydroxylase inhibitoren zur behandlung von diabetes
DK1682482T3 (da) Fremgangsmåde til forbedring af spredningsegenskaber af fedtalkoholforbindelser, produkter, og anvendelser deraf
RU2003113761A (ru) Противовоспалительное средство